Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Diagn Microbiol Infect Dis ; 96(1): 114914, 2020 Jan.
Article in English | MEDLINE | ID: mdl-31704066

ABSTRACT

Russia introduced PCV13 in 2014. We studied the serotype composition of S. pneumoniae isolated from the nasopharynx of healthy children younger than 6 years in St. Petersburg, Smolensk, Perm, Krasnoyarsk, Khanty-Mansiysk and Khabarovsk, between 2016 and 2018. 2.4% of children had completed a 3-dose course of PCV13, while 25.6% had received 1 or 2 doses. Pneumococcal DNA detection by PCR demonstrated S. pneumoniae in 37.2% of samples with regional variation between sites (27.3 to 56.9%). There was little difference between vaccinated, partially vaccinated and un-vaccinated children. Children who had received at least 1 dose of PCV13 had lower carriage rates of vaccine serotypes than their unvaccinated peers (49.9 vs. 61.4%; p < 0.001). Children who had received at least 1 dose of PCV13 showed increased carriage rates of non-vaccine serotypes (50 vs 38.6%; P < 0.001). Especially serogroup 15AF was more prevalent among fully immunized children than among their peers (12.5 vs 2.7%; P < 0.05).


Subject(s)
Carrier State/microbiology , Immunization Programs , Nasopharynx/microbiology , Pneumococcal Infections/prevention & control , Pneumococcal Vaccines/administration & dosage , Streptococcus pneumoniae/classification , Carrier State/epidemiology , Child , Child, Preschool , Healthy Volunteers , Humans , Infant , Infant, Newborn , Pneumococcal Infections/epidemiology , Prevalence , Russia/epidemiology , Serogroup , Streptococcus pneumoniae/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...